The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

Tc00.1047053503893.70  -  reductase

Trypanosoma cruzi strain CL Brener

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Tc00.1047053503893.70

 

High impact information on Tc00.1047053503893.70

  • Interestingly, immunoprecipitation experiments revealed that anti-TcOYE polyclonal antibody abolished major reductase activities of the lysates toward these drugs, identifying TcOYE as a key drug-metabolizing enzyme by which quinone drugs have their mechanism of action [2].
  • The trypanosomatid flavoprotein disulfide reductase, trypanothione reductase, is shown to catalyze one-electron reduction of suitably substituted naphthoquinone and nitrofuran derivatives [1].
  • A ribonucleotide reductase inhibitor, hydroxyurea, at concentrations up to 2 mM had no effect on the growth of giardia [3].
  • The absence of detectable ribonucleotide reductase, the failure to incorporate purine nucleobases and nucleosides into DNA to any significant extent, the ready incorporation of deoxynucleosides into DNA, and the demonstration of a purine deoxynucleoside kinase suggest that giardia are dependent on the salvage of exogenous deoxynucleosides [3].
  • We report the isolation and characterization of a genomic clone containing the open reading frame sequence for 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase from Trypanosoma cruzi, the causative agent of Chagas' disease [4].
 

Biological context of Tc00.1047053503893.70

 

Anatomical context of Tc00.1047053503893.70

  • This is the first demonstration of a soluble eukaryotic HMG-CoA reductase and also the first report on the presence of an enzyme of the isoprenoid biosynthesis pathway in glycosomes [8].
  • Mercaptopyridine-N-oxide, an NADH-fumarate reductase inhibitor, blocks Trypanosoma cruzi growth in culture and in infected myoblasts [9].
  • Determination of succinate cytochrome c reductase and glucose-6-phosphatase activities, as well as of total amounts of DNA and RNA in the purified fraction, indicates a negligible contamination from other cellular organelles [10].
 

Associations of Tc00.1047053503893.70 with chemical compounds

  • In epimastigotes, the naphthoimidazole inhibited the activity of succinate cytochrome c reductase [11].
  • The purified [C58S]trypanothione reductase showed spectral properties similar to the oxidised wild-type enzyme but, unlike the wild-type enzyme, did not acquire the characteristic charge-transfer complex of the EH2 form on addition of NADPH [7].
  • Immunochemical studies on the FAD-dependent NADPH-cytochrome c reductase from Trypanosoma cruzi [12].
  • The results are in complete agreement with recent gene cloning and expression studies which showed that T. cruzi HMG-CoA reductase lacks the NH2-terminal membrane-spanning sequence [8].
  • The subcellular localization of 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase, which catalyzes the first committed step of the mevalonate pathway, was investigated in Trypanosoma cruzi epimastigotes using well-established cell fractionation procedures [8].
 

Other interactions of Tc00.1047053503893.70

  • The relative steady state concentration of mRNAs of four housekeeping single-copy type Trypanosoma cruzi genes (actin, triosephosphate isomerase, trypanothion reductase and the ribosomal protein S4) was analyzed throughout the growth curve [13].

References

  1. "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease. Henderson, G.B., Ulrich, P., Fairlamb, A.H., Rosenberg, I., Pereira, M., Sela, M., Cerami, A. Proc. Natl. Acad. Sci. U.S.A. (1988) [Pubmed]
  2. A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. Kubata, B.K., Kabututu, Z., Nozaki, T., Munday, C.J., Fukuzumi, S., Ohkubo, K., Lazarus, M., Maruyama, T., Martin, S.K., Duszenko, M., Urade, Y. J. Exp. Med. (2002) [Pubmed]
  3. Purine deoxynucleoside salvage in Giardia lamblia. Baum, K.F., Berens, R.L., Marr, J.J., Harrington, J.A., Spector, T. J. Biol. Chem. (1989) [Pubmed]
  4. A soluble 3-hydroxy-3-methylglutaryl-CoA reductase in the protozoan Trypanosoma cruzi. Peña-Díaz, J., Montalvetti, A., Camacho, A., Gallego, C., Ruiz-Perez, L.M., Gonzalez-Pacanowska, D. Biochem. J. (1997) [Pubmed]
  5. Rotenone at high concentrations inhibits NADH-fumarate reductase and the mitochondrial respiratory chain of Trypanosoma brucei and T. cruzi. Hernandez, F.R., Turrens, J.F. Mol. Biochem. Parasitol. (1998) [Pubmed]
  6. Succinate-dependent metabolism in Trypanosoma cruzi epimastigotes. Denicola-Seoane, A., Rubbo, H., Prodanov, E., Turrens, J.F. Mol. Biochem. Parasitol. (1992) [Pubmed]
  7. Site-directed mutagenesis of the redox-active cysteines of Trypanosoma cruzi trypanothione reductase. Borges, A., Cunningham, M.L., Tovar, J., Fairlamb, A.H. Eur. J. Biochem. (1995) [Pubmed]
  8. 3-Hydroxy-3-methyl-glutaryl-CoA reductase in Trypanosoma (Schizotrypanum) cruzi: subcellular localization and kinetic properties. Concepcion, J.L., Gonzalez-Pacanowska, D., Urbina, J.A. Arch. Biochem. Biophys. (1998) [Pubmed]
  9. Mercaptopyridine-N-oxide, an NADH-fumarate reductase inhibitor, blocks Trypanosoma cruzi growth in culture and in infected myoblasts. Turrens, J.F., Newton, C.L., Zhong, L., Hernandez, F.R., Whitfield, J., Docampo, R. FEMS Microbiol. Lett. (1999) [Pubmed]
  10. Purification of an adenylyl cyclase-containing plasma membrane fraction from Trypanosoma cruzi. Zingales, B., Carniol, C., Abramhamsohn, P.A., Colli, W. Biochim. Biophys. Acta (1979) [Pubmed]
  11. Effect of a beta-lapachone-derived naphthoimidazole on Trypanosoma cruzi: identification of target organelles. Menna-Barreto, R.F., Henriques-Pons, A., Pinto, A.V., Morgado-Diaz, J.A., Soares, M.J., De Castro, S.L. J. Antimicrob. Chemother. (2005) [Pubmed]
  12. Immunochemical studies on the FAD-dependent NADPH-cytochrome c reductase from Trypanosoma cruzi. Kuwahara, T., Paulin, J.J., Cosgrove, W.B., Agosin, M. Arch. Biochem. Biophys. (1988) [Pubmed]
  13. The stabilization of housekeeping transcripts in Trypanosoma cruzi epimastigotes evidences a global regulation of RNA decay during stationary phase. Cevallos, A.M., Pérez-Escobar, M., Espinosa, N., Herrera, J., López-Villaseñor, I., Hernández, R. FEMS Microbiol. Lett. (2005) [Pubmed]
 
WikiGenes - Universities